In this study we describe likely pathogenic or rare missense variants in the BMPR2 pathway gene SMAD6 in 4 of 32 (12.5%) patients with CHD-APAH and in 2 out of 311 (0.64%) patients with IPAH. The gene discussed is BMPR2; the disease is coronary artery disorder.